Literature DB >> 29143121

Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.

Yuto Aoki1,2, Junko Aida3, Youichi Kawano3,4, Ken-Ichi Nakamura3, Naotaka Izumiyama-Shimomura3, Naoshi Ishikawa3, Tomio Arai5, Yoshiharu Nakamura6, Nobuhiko Taniai6, Eiji Uchida6, Kaiyo Takubo3, Toshiyuki Ishiwata7.   

Abstract

BACKGROUND: Congenital biliary dilatation (CBD) is a congenital malformation involving both dilatation of the extrahepatic bile duct and pancreaticobiliary maljunction. Persistent reflux of pancreatic juice injures the biliary tract mucosa, resulting in chronic inflammation and higher rates of carcinogenesis in the biliary tract, including the gallbladder. Telomeres are repetitive DNA sequences located at the ends of chromosomes. Chromosomal instability due to telomere dysfunction plays an important role in the carcinogenesis of many organs. This study was performed to determine whether excessive shortening of telomeres occurs in the gallbladder mucosa of patients with CBD.
METHODS: Resected gallbladders were obtained from 17 patients with CBD, ten patients with cholecystolithiasis without pancreatic juice reflux, and 17 patients with normal gallbladders (controls) (median age of each group of patients: 37, 50, and 53 years, respectively). The telomere lengths of the gallbladder epithelium were measured by quantitative fluorescence in situ hybridization using tissue sections, and the normalized telomere-to-centromere ratio (NTCR) was calculated.
RESULTS: The NTCRs in the CBD, cholecystolithiasis, and control groups were 1.24 [interquartile range (IQR) 1.125-1.52], 1.96 (IQR 1.56-2.295), and 1.77 (IQR 1.48-2.53), respectively. The NTCR in the CBD group was significantly smaller than that in the cholecystolithiasis and control groups (p = 0.003 and 0.004, respectively), even in young patients.
CONCLUSIONS: Our findings indicate that telomere shortening in the gallbladder mucosa plays an important role in the process of carcinogenesis in patients with CBD. These results support the recommendation of established guidelines for prophylactic surgery in patients with CBD because CBD is a premalignant condition with excessive telomere shortening.

Entities:  

Keywords:  Carcinogenesis; Congenital biliary dilatation; Pancreaticobiliary maljunction; Q-FISH; Telomere

Mesh:

Year:  2017        PMID: 29143121     DOI: 10.1007/s00535-017-1411-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  60 in total

Review 1.  Relationship between pancreaticobiliary maljunction and gallbladder carcinoma: meta-analysis.

Authors:  Yi-Lei Deng; Nan-Sheng Cheng; Yi-Xin Lin; Rong-Xing Zhou; Chen Yang; Yan-Wen Jin; Xian-Ze Xiong
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-12

2.  Chromosomal instability and telomere lengths of each chromosomal arm measured by Q-FISH in human fibroblast strains prior to replicative senescence.

Authors:  Kaiyo Takubo; Junko Aida; Naotaka Izumiyama; Naoshi Ishikawa; Mutsunori Fujiwara; Steven S S Poon; Hiroshi Kondo; Makoto Kammori; Masaaki Matsuura; Motoji Sawabe; Tomio Arai; Duncan M Baird; Ken-Ichi Nakamura
Journal:  Mech Ageing Dev       Date:  2010-09-09       Impact factor: 5.432

Review 3.  Changes of telomere length with aging.

Authors:  Kaiyo Takubo; Junko Aida; Naotaka Izumiyama-Shimomura; Naoshi Ishikawa; Motoji Sawabe; Rie Kurabayashi; Hiroaki Shiraishi; Tomio Arai; Ken-Ichi Nakamura
Journal:  Geriatr Gerontol Int       Date:  2010-07       Impact factor: 2.730

Review 4.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

5.  Precancerous mucosal changes in the gallbladder of patients with occult pancreatobiliary reflux.

Authors:  Jin Kan Sai; Masafumi Suyama; Bunsei Nobukawa; Yoshihiro Kubokawa; Kazuko Yokomizo; Nobuhiro Sato
Journal:  Gastrointest Endosc       Date:  2005-02       Impact factor: 9.427

6.  Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.

Authors:  Yoshiro Matsumoto; Hideki Fujii; Jun Itakura; Masanori Matsuda; Yang Yang; Bunsei Nobukawa; Kohichi Suda
Journal:  Langenbecks Arch Surg       Date:  2003-04-09       Impact factor: 3.445

7.  Quantitative fluorescence in situ hybridization measurement of telomere length in skin with/without sun exposure or actinic keratosis.

Authors:  Hiroyuki Ikeda; Junko Aida; Atsushi Hatamochi; Yoichiro Hamasaki; Naotaka Izumiyama-Shimomura; Ken-Ichi Nakamura; Naoshi Ishikawa; Steven S Poon; Mutsunori Fujiwara; Ken-Ichiro Tomita; Naoki Hiraishi; Mie Kuroiwa; Masaaki Matsuura; Yukihiro Sanada; Youichi Kawano; Tomio Arai; Kaiyo Takubo
Journal:  Hum Pathol       Date:  2013-10-19       Impact factor: 3.466

8.  Pancreatobiliary reflux and the length of a common channel.

Authors:  Terumi Kamisawa; Masafumi Suyama; Naotaka Fujita; Hiroyuki Maguchi; Keiji Hanada; Seiyo Ikeda; Yoshinori Igarashi; Takao Itoi; Mitsuhiro Kida; Goro Honda; Jinkan Sai; Jun Horaguchi; Kuniyuki Takahashi; Takamitsu Sasaki; Kensuke Takuma; Fumihide Itokawa; Hisami Ando; Hiroo Takehara
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-11       Impact factor: 7.027

9.  Diagnostic criteria for congenital biliary dilatation 2015.

Authors:  Yoshinori Hamada; Hisami Ando; Terumi Kamisawa; Takao Itoi; Naoto Urushihara; Tsugumichi Koshinaga; Takeshi Saito; Hideki Fujii; Yoshiki Morotomi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2016-05-03       Impact factor: 7.027

10.  Gradual telomere shortening and increasing chromosomal instability among PanIN grades and normal ductal epithelia with and without cancer in the pancreas.

Authors:  Yoko Matsuda; Toshiyuki Ishiwata; Naotaka Izumiyama-Shimomura; Hideki Hamayasu; Mutsunori Fujiwara; Ken-Ichiro Tomita; Naoki Hiraishi; Ken-Ichi Nakamura; Naoshi Ishikawa; Junko Aida; Kaiyo Takubo; Tomio Arai
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.